Dario Rodriguez-Rubio
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Cost of rimegepant and lasmiditan associated adverse events, for acute treatment in migraine in Spain.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: January 09, 2026
Cost-effectiveness of apixaban in non-valvular atrial fibrillation (NVAF) based on effectiveness data from a Spanish study in clinical practice (real-world evidence).
Journal: Expert review of cardiovascular therapy
Published: February 07, 2025
Cost-effectiveness of cetuximab combined with radiotherapy versus radiotherapy alone in locally advanced head and neck cancer in Spain.
Journal: Journal of comparative effectiveness research
Published: January 10, 2025
Economic impact of individualized antimicrobial dose optimization in the critically ill patient in Spain.
Journal: Frontiers in pharmacology
Published: October 04, 2024
HIV-1 resistance and virological failure to treatment with the integrase inhibitors bictegravir, cabotegravir, and dolutegravir: a systematic literature review.
Journal: AIDS reviews
Published: August 12, 2024
Effectiveness of pharmacological treatments for COVID-19 due to SARS-CoV-2: a systematic literature review.
Journal: Frontiers in pharmacology
Published: July 24, 2024
Corrigendum for HIV-1 resistance and virological failure to treatment with the integrase inhibitors bictegravir, cabotegravir, and dolutegravir: a systematic literature review.
Journal: AIDS reviews
Published: January 01, 2024
Cost-effectiveness of somatrogon in the Spanish pediatric population with growth hormone deficiency.
Cost-effectiveness of somatrogon in the Spanish pediatric population with growth hormone deficiency.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: September 24, 2023
Cost-effectiveness of weekly gastro-resistant risedronate 35 mg, compared with weekly alendronate 70 mg tablets, in the treatment of postmenopausal osteoporosis in Spain.
Journal: Journal of comparative effectiveness research
Published: September 15, 2023
Cost-effectiveness of apixaban and rivaroxaban in thromboprophylaxis of cancer patients treated with chemotherapy in Spain.
Journal: Journal of medical economics
Published: August 21, 2023
Cost-effectiveness of cladribine tablets and dimethyl fumarate in the treatment of relapsing remitting multiple sclerosis in Spain.
Journal: Journal of comparative effectiveness research
Published: January 27, 2023
Comparison of the design and methodology of Phase 3 clinical trials of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) and dolutegravir-based dual therapy (DTG) in HIV: a systematic review of the literature.
Journal: Expert review of anti-infective therapy
Published: November 18, 2022
Last Updated: 09/26/2026